India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
A moment during a risky surgery "Dr. Saap, is his treatment possible?'' Vimala Kashyap of Sunsari Chatra asked me. She had sent such a video on Facebook Messenger, who is at high risk of pregnancy. As soon as I saw the video of that pregnant woman who was going through a complicated problem, I said, 'Treatment is possible.' I had to give this answer both ethically and professionally. Because I am an obstetrician. My job is to support safe delivery. Another thing, I am human. A complex patient who is disadvantaged. To save her life, I am more motivated by my human feelings. Vimala said, "He needs treatment, but he doesn't have anything." "Nothing" means no money for treatment. I said in reply, 'I will do the work on my behalf for free. I will also ask for help from the hospital. It was seven o'clock in the morning. That's all we talked about. Last week of May. It was around 9:30 pm. The pregnant woman was brought to the hospital ...